Researchers track Real-World use of eye drug in japan
NCT ID NCT06929143
Summary
This study looks back at existing health records to understand how doctors in Japan use aflibercept 8 mg, an injection for two common eye conditions that cause blurry vision. Researchers will analyze data from about 3,000 patients who already received this approved treatment as part of their regular care. The goal is to learn more about the patients and how often they received the injections over one year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bayer
Osaka, 5300001, Japan
Conditions
Explore the condition pages connected to this study.